CD19-directed CAR-T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CD19-directed CAR-T cells, covering 2017-07-02 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma [Phase 1]